in this issue
Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals
Botanical and Plant-Derived Drug Industry to Blossom
12:51 PM MST | February 27, 2009 | DEEPTI RAMESH
The global botanical and plant-derived drug market is expected to blossom by 2013, reaching a combined total of $32.9 billion a compound annual growth rate (CAGR) of 11%, according to a new study by BCC Research (Wellesley, MA). That is an increase from $19.5 billion last year, it adds Botanical drugs are those that are FDA approved under the botanical drug pathway; plant-derived drugs are those under a new FDA classification that are botanicals and contain a mixture of plant-derived and synthetic substances, BCC says. The plant-derived drug sector commands the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: